期刊文献+

^(125)I放射粒子在肿瘤介入治疗中的应用 被引量:27

Tumor interventional therapy using ^(125)I seed
下载PDF
导出
摘要 目的探索采用介入微创技术进行放射粒子病灶内植入的可行性、安全性及疗效;比较不同影像设备在粒子植入术中的作用及优缺点。方法入选30例患者,其中15例为晚期肿瘤转移患者,15例为失去手术机会的食管癌患者。粒子植入方法:在B超或CT定位下行经皮穿刺病灶内粒子植入术;在DSA监视下将捆绑有放射粒子的食管支架植入到食管病变部位。结果在B超、CT及DSA监视下,除因操作原因造成食管内照射支架上丢失一颗放射粒子外,所有放射粒子均准确植入到位。术后随访,患者临床症状均有明显改善;未发现局部皮肤坏死、出血、感染、放射性肺炎、食管穿孔等与粒子照射相关的并发症;手术前后连续血象、免疫指标复查未发现显著性变化。ECT复查:放射源未发现泄漏。病灶复查:15例食管癌患者1个月后胸部CT复查示13例病变厚度和体积较术前有所缩小,2例病变增大,3例随访近13个月,CT复查病变厚度较术前明显变薄;5例直接置入无膜内照射支架患者中3例术后3个月胃镜复查并活检提示支架捆绑粒子部位肿瘤明显退缩,未发现肿瘤细胞生长。15例经皮穿刺植入粒子的患者在术后2个月病变明显缩小。结论采用介入微创技术进行放射粒子病灶内植入是可行的、安全的,疗效是明确的。 Objective To explore the feasibility, safety, and effect of interventional technology for inserting ^125Ⅰ seeds into tumor focus and to study the advantage or shortcome of different image equipments used in seed implantation. Methods Fifteen cases of advanced stage tumor with metastasis and another 15 cases of advanced unresectable esophageal cancer were enrolled. Method of seed implantation was carried out by inserting ^125Ⅰ seeds into tumor foci throngh percutaneous puncture under ultrasound or CT guidance, and placed the esophageal stent binding with ^125Ⅰ seed to the diseased esophageal segment under DSA. Results All ^125Ⅰseeds were successfully released to the target places under ultrasound, CT and DSA guidance, except one seed was found to be lost from one esophageal ^125Ⅰ seed irradiated stent due to misoperatlon. A follow-up showed obvious improvement of clinical symptom, no significant changes of hemogram, immunity markers, and no complications including esophageal perforation, hemorrhage, and skin necrosis. No radiation seeds shedded during the releasing processes by ECT. One month follow- up by CT showed the target places were thinned in 13 cases, thickened in 2 cases. 3 cases had been followed-up for 13 months, CT revealed the obvious thinning of the foci. Three-month follow up with gastroendoscopy and biopsy demonstrated that the foci within the ^125ⅠI seede binding stent placement segment resolved markedly, with no tumor ceils found in biopsy for 3 of 5 cases. 15 cases by percutaneous puncture implantation had been followed-up for two months, showed the foci becoming obviously small urder diagnostic imaging. Conclusions It is feasible and safe to insert ^125Ⅰseeds into tumor foci by interventional technology and the confirmed effect is favorable.
出处 《介入放射学杂志》 CSCD 2005年第6期613-617,共5页 Journal of Interventional Radiology
关键词 ^125Ⅰ粒子 近距离放疗 肿瘤治疗 介入放射 ^125Ⅰ seed Braehytherapy Tumor therapy Interventionalradiology
  • 相关文献

参考文献11

  • 1王俊杰.放射性粒子近距离治疗的生物学基础(第1版)[M].北京:北京医科大学出版社,2001.172.
  • 2黄振国,张雪哲,王武,洛小林,王继英.CT导引下^(125)I粒子植入在治疗恶性肿瘤中的应用[J].中华放射学杂志,2004,38(9):921-925. 被引量:135
  • 3Merrick GS,Butler WM,Galbreath RW,et al.Five-year biochemical outcome following permanent interstitial brachytherapy for clinical T-T protate cancer[J].Int J Radiation Oncology Bio Phys,2001,51:41-48.
  • 4谢大业,刘忠,胡国平.胰、胆、肝区癌组织间放射治疗[J].肝胆胰外科杂志,2002,14(3):142-144. 被引量:26
  • 5Mohinddin M,Rosato F,Barbot D,et al.Long term results of combined modality treatment with 125 I implantation for carcinoma of the pancreas.Int J Radiat Oncol Biol Phys,1992,23:305-311.
  • 6Radge H,Blasko JC,Grimm PD,et al.Brachytherapy for clinically localized prostate cancer:results at 7-and 8-year follow-up.Semin Surg Pncol,1997,13:438-443.
  • 7Martinez MR,Nag S,Nieroda CA,et al.Iodine-125 brachytherapy in the treatment of colorectal adenocarcinoma metastatic to the liver.Cancer,1999,85:1218-1225.
  • 8Videtic GM,Gaspar LE,Zamorano L,et al.Use of the RTOG recursive partitioning analysis to validate the benefit of iodine-125implants in the primary treatment of malignant gliomas.Int J Radiat Oncol Biol Phys,1999,45:687-692.
  • 9罗开元,李波,杨嵘,王明春,刘文卓,曹卫弘,黄明龙.^(125)I粒子组织间放射治疗恶性肿瘤的临床应用[J].中华医学杂志,2001,81(12):754-755. 被引量:103
  • 10刘培云,王树忠,朱瑾,熊菊英,胡培.^(125)I银(铂)组织间粒子植入放疗医护人员受照剂量[J].中国辐射卫生,2002,11(1):39-40. 被引量:6

二级参考文献18

  • 1谢大业,沈坤炜,夏长华.肺癌规范性手术及术中组织间放疗[J].现代诊断与治疗,1994,5(4):203-205. 被引量:12
  • 2方永鑫,张海鹰,余征,袁玫,林星石,费丽华,李力,李华,田嘉禾,黄靖香,檀华,蒋彦永.放射性碘标记CL-3体外肿瘤细胞结合及瘤内注射动物实验研究[J].中华核医学杂志,1996,16(1):36-38. 被引量:3
  • 3Zelefsky MJ, Hollister T, Raben A, et al. Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer. Int J Radiat Oncol Biol Phys,2000,47:1261-1266.
  • 4Willins J, Wallner K. CT-based dosimetry for transperineal I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys,1997,39:347-353.
  • 5Molloy JA, Williams MB. Treatment planning considerations and quality assurance for CT-guided transischiorectal implantation of the prostate. Med Phys,1999,26:1943-1951.
  • 6Martinez-Monge R, Nag S, Nieroda CA, et al. Iodine-125 brachytherapy in the treatment of colorectal adenocarcinoma metastatic to the liver. Cancer,1999,85:1218-1225.
  • 7Vikram B, Mishra S.Permanent iodine-125 implants in postoperative radiotherapy for head and neck cancer with positive surgical margins. Head Neck,1994,16:155-157.
  • 8Kumar PP, Patil AA, Leibrock LG,et al. Continuous low dose rate brachytherapy with high activity iodine-125 seeds in the management of meningiomas. Int J Radiat Oncol Biol Phys,1993,25:325-328.
  • 9Lee DJ, Liberman FZ, Park RI, et al. Intraoperative I-125 seed implantation for extensive recurrent head and neck carcinomas. Radiology,1991,178:879-882.
  • 10Heelan RT, Hilaris BS, Anderson LL, et al. Lung tumors: percutaneous implantation of I-125 sources with CT treatment planning. Radiology, 1987,164:735-740.

共引文献258

同被引文献206

引证文献27

二级引证文献172

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部